Alpha DNA Investment Management’s Phillips 66 PSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,089
Closed -$352K 137
2024
Q4
$352K Buy
3,089
+200
+7% +$25.4K 0.13% 180
2024
Q3
$380K Buy
2,889
+233
+9% +$31.5K 0.14% 185
2024
Q2
$375K Sell
2,656
-1,877
-41% -$278K 0.15% 175
2024
Q1
$740K Buy
4,533
+1,232
+37% +$178K 0.27% 84
2023
Q4
$439K Sell
3,301
-3,622
-52% -$433K 0.17% 148
2023
Q3
$832K Buy
+6,923
New +$777K 0.34% 55
2021
Q2
Sell
-478
Closed -$38K 511
2021
Q1
$38K Sell
478
-56
-10% -$4.39K 0.04% 207
2020
Q4
$37K Buy
+534
New +$31.3K 0.04% 202

Other funds holding PSX

Alpha DNA Investment Management's PSX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Phillips 66 (PSX) in Q1 2025, closing a stake of 3,089 shares — an estimated $352K sold.

Alpha DNA Investment Management first reported a position in PSX in Q4 2020 and held it in 8 quarters. The position peaked at $832K in Q3 2023. 1,791 funds tracked by Wall St. Rank hold PSX as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Phillips 66 position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,089 Phillips 66 shares in Q1 2025, an estimated $352K.
  • Alpha DNA Investment Management first reported a position in Phillips 66 in Q4 2020 and held it in 8 quarters.
  • Alpha DNA Investment Management's Phillips 66 position peaked at $832K in Q3 2023.
  • 1,791 funds tracked by Wall St. Rank held Phillips 66 as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.